Disclosures for "Treatment Outcomes and Healthcare Resource Utilization Among People Living with Focal Onset Epilepsy and Deemed to be Drug Resistant in Clinical Practices in the United States"
-
Dr. Mao has received personal compensation for serving as an employee of Cerevel Threrapeutics. Dr. Mao has stock in Cerevel Threrapeutics.
-
Dr. Takahashi has received personal compensation for serving as an employee of Cerevel Therapeutics. Dr. Takahashi has stock in Cerevel Therapeutics.
-
Ms. Cheng has received personal compensation for serving as an employee of Analysis Group, Inc..
-
Miss Xu has received personal compensation for serving as an employee of Analysis Group, Inc..
-
Miss Boca has received personal compensation for serving as an employee of Analysis Group, Inc.. The institution of Miss Boca has received research support from Acadia Pharmaceuticals Inc.
-
Dr. Dandurand has received personal compensation for serving as an employee of Cerevel. Dr. Dandurand has received personal compensation for serving as an employee of Otsuka. Dr. Dandurand has stock in Cerevel Therapeutics. An immediate family member of Dr. Dandurand has stock in Velocit . An immediate family member of Dr. Dandurand has stock in Cerebus.
-
Mr. Song has received personal compensation for serving as an employee of Analysis Group .